期刊文献+

GST-hPlk2融合蛋白表达载体的构建及其在原核细胞中的表达

Construction of GST-hPlk2 fusion protein expression vectors and the expression in prokaryotic cells
下载PDF
导出
摘要 目的构建GST-hPlk2融合蛋白表达载体,并在原核细胞大肠埃希菌(E.coli)中诱导表达。方法从人HEK293细胞中提取mRNA,反转录为cDNA。用PCR方法扩增出hPlk2基因全长,通过BamHⅠ和XhoⅠ酶切位点将其定向插入pGEX-4T-2载体中,构建原核表达质粒pGEX-4T-2-hPlk2,并转化E.coli DH5α,筛选阳性重组子,通过限制性内切酶酶切电泳鉴定和DNA序列测定正确后,转入E.coli BL21中,经异丙基硫代β-D半乳糖苷大量诱导表达,SDS-PAGE电泳和Western blot鉴定。结果酶切电泳及测序结果证明,成功构建了原核表达质粒GST-hPlk2,并用Western blot方法证实了GST-hPlk2融合蛋白的表达。结论成功构建了GST-hPlk2原核表达载体,并证实了其在原核细胞E.coli中的表达,为进一步纯化Plk2及研究其结构与功能提供了前提基础。 Objective To construct GST-hPlk2 fusion protein expression vector and induce its expression in Esche-richia coli (E. coli). Methods Total mRNA was extracted from HEK293 ceils, and cDNA was formed by reverse tran- scription. The hPlk2 coding sequence was amplified by polymerase chain reaction (PCR) and subcloned into pGEX-4T-2 vector. The positive recombinant was identified by restriction enzyme digestion and DNA sequencing. Then they were trans- formed into E. coli BI221, induced by IPTG and identified by SDS-PAGE and Western blot. Results The prokaryotic ex- pression plasmid pGEX-4T-2-hPlk2 was successfully constructed and confirmed by enzyme digestion and sequencing. The GST-hPlk2 fusion proteins were expressed and confirmed by Western blot. Conclusions The prokaryotic expression plas- mid of bPlk2 was successfully constructed and the expression of fusion proteins in E. coli was confirmed. This study pro- vides the basis for the further research on purifying Plk2 protein and the biological function of Plk2.
出处 《山东医药》 CAS 2012年第16期1-3,6,共4页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30800415) 辽宁省科技计划项目(2009225010-15)
关键词 hPlk2 原核细胞 表达 融合蛋白 hPlk2 prokaryotic cells expression fusion proteins
  • 相关文献

参考文献14

  • 1Archambault V, Glover DM. Polo-like kinases : conservation and di- vergence in their functions and regulation [J]. Nat Rev Mol Cell Biol, 2009,10(4) :265-275.
  • 2Eckerdt F, Yuan J, Strebhardt K. Polo-like kinases and oncogenesis [J]. Oncogene, 2005,24(2) :267-276.
  • 3Andrysik Z, Bemstein WZ, Deng L, et el. The novel mouse Polo- like kinase 5 responds to DNA damage and localizes in the nucleolus [ J]. Nucleic Acids Res, 2010,38 (9) :2931-2943.
  • 4Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer [ J ]. Nat Rev Drug Discov, 2009,8 (7) :547-566.
  • 5Matsumoto T, Wang PY, Ma W, et al. Polo-like kinases mediate cell survival in mitochondrial dysfunction [ J ]. Proc Natl Acad Sci U S A, 2009,106 (34) : 14542-14546.
  • 6Syed N, Smith P, Sullivan A, et al. Transcriptional silencing of Po- lo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malig- nancies [ J ]. Blood, 2006,107 ( 1 ) :250-256.
  • 7Benetatos L, Dasoula A, Hatzimichael E, et al. Polo-like kinase 2 ( SNK/PLK2 ) is a novel epigenetically regulated gene in acute mye- loid leukemia and myelodysplastic syndromes: genetic and epigenet- ic interactions [J]. Ann Hematol, 2011,90(9) :1037-1045.
  • 8Smith P, Syed N, Crook T. Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3 [ J ]. Cell Cycle, 2006,5 ( 12 ) : 1262-1264.
  • 9Zuber J, Tchernitsa O1, Hinzmann B, et al. A genome-wide survey of RAS transformation targets [ J ]. Nat Genet, 2000, 24 ( 2 ) :144-152.
  • 10Pellegrino R, Calvisi DF, Ladu S, et al. Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular car- cinoma [ J ]. Hepatology, 2010,51 (3) :857-868.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部